Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S.

Since I upgraded to a Strong Buy rating on Steris plc (NYSE: STE ) in March 2025, the stock price has surged by more than 11%. I think Steris will potentially benefit from the TrumpAnalyst’s Disclosure: I/we have a beneficial long position in the shares of STE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whos ...